Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emmes Group is an industry-leading specialty and technology-driven contract research organization with over 47 years of experience. It has supported more than 2,150 Phase I–IV trials in over 90 countries and is recognized for integrating advanced digital and AI technologies into all aspects of clinical trial management. Its expertise spans vaccines, infectious diseases, ophthalmology, neuroscience, rare diseases, cell and gene therapies, oncology, hematology, maternal/child health, medical devices and more. The company’s Veridix AI unit accelerates adoption of generative AI to optimize global clinical research infrastructure[1][2][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emmes Group.